How might Cerus modify its pathogen reduction technology to expand its use beyond platelets and plasma?

Introduction

To expand Cerus' pathogen reduction technology beyond platelets and plasma, we need to explore new applications, potential modifications, and market opportunities. I'll analyze the current product, identify key stakeholders, explore pain points, and propose innovative solutions to broaden the technology's reach.

Step 1

Clarifying Questions (5 mins)

• Looking at Cerus' current product offering, I'm thinking about the specific advantages of their pathogen reduction technology. Could you provide more details on the key differentiators of their technology compared to other methods in the market?

Why it matters: Helps identify unique selling points to leverage in new applications Expected answer: Cerus' technology is highly effective and doesn't compromise blood component quality Impact on approach: Would focus on maintaining these advantages while exploring new applications

• Considering the potential expansion, I'm curious about the regulatory landscape. What are the current regulatory requirements for pathogen reduction in blood components other than platelets and plasma?

Why it matters: Determines the feasibility and potential barriers to entry for new applications Expected answer: Varied regulations across different blood components and regions Impact on approach: Would prioritize applications with clearer regulatory pathways or high unmet needs

• Thinking about the broader healthcare ecosystem, I'm wondering about the current unmet needs in blood safety beyond platelets and plasma. What are the most pressing challenges in ensuring the safety of other blood components or related products?

Why it matters: Identifies potential high-impact areas for expansion Expected answer: Growing concerns about emerging pathogens in red blood cells or stem cell products Impact on approach: Would focus on addressing these specific challenges in solution development

• Considering the company's resources and capabilities, I'm interested in understanding Cerus' current R&D focus. Are there any ongoing research initiatives or partnerships aimed at expanding the technology's applications?

Why it matters: Helps align proposed solutions with existing company efforts Expected answer: Some early-stage research into red blood cell applications Impact on approach: Would build upon existing research and suggest complementary directions